The association between proton pump inhibitors and hyperparathyroidism: a potential mechanism for increased fracture—results of a large observational cohort study

Donal Fitzpatrick,Rosaleen Lannon,Eamon Laird,Mary Ward,Leane Hoey,Catherine F. Hughes,J. J. Strain,Conal Cunningham,Helene McNulty,Anne M. Molloy,Kevin McCarroll,Fitzpatrick, Donal
DOI: https://doi.org/10.1007/s00198-023-06867-8
2023-08-03
Osteoporosis International
Abstract:Proton pump inhibitors (PPIs) are associated with increased risk of osteoporotic fracture; however, the mechanism is unclear. PPI users taking calcium supplements were more likely to have hyperparathyroidism compared to non-users (OR 1.56, CI 1.08–2.23, p = 0.018). This highlights the importance of monitoring PPI use, especially in older adults.
endocrinology & metabolism
What problem does this paper attempt to address?